These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30772049)

  • 1. Commentary on Jauhar and Hayes.
    Hengartner MP
    Addict Behav; 2019 Oct; 97():131. PubMed ID: 30772049
    [No Abstract]   [Full Text] [Related]  

  • 2. Authors' response to a critique by Jauhar and Hayes of 'A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guideline evidence-based?'.
    Davies J; Read J
    Addict Behav; 2019 Oct; 97():127-130. PubMed ID: 30737005
    [No Abstract]   [Full Text] [Related]  

  • 3. [Multisystemic therapy of adolescents with conduct disorders].
    de la Peña-Olvera FR
    Salud Publica Mex; 2003; 45 Suppl 1():S124-31. PubMed ID: 12602155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [2-Dimethylaminoethanol in behavior disorders of childhood].
    KNOBEL M; ABRAMOVSKY H
    Sem Med; 1961 Sep; 119():939-44. PubMed ID: 14457266
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mixed disorders of conduct and emotions].
    Arai S; Ichikawa H
    Ryoikibetsu Shokogun Shirizu; 2003; (40):31-6. PubMed ID: 14626057
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological aspects of the treatment of conduct disorder in children and adolescents.
    Tcheremissine OV; Lieving LM
    CNS Drugs; 2006; 20(7):549-65. PubMed ID: 16800715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mood stabilizers and anticonvulsants.
    Kowatch RA; Bucci JP
    Pediatr Clin North Am; 1998 Oct; 45(5):1173-86, ix-x. PubMed ID: 9884681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy profiles of psychopharmacology: divalproex sodium in conduct disorder.
    Khanzode LA; Saxena K; Kraemer H; Chang K; Steiner H
    Child Psychiatry Hum Dev; 2006; 37(1):55-64. PubMed ID: 16927177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of placebos in clinical trials involving children and adolescents.
    Malone RP; Simpson GM
    Psychiatr Serv; 1998 Nov; 49(11):1413-4, 1417. PubMed ID: 9826239
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary on Border et al. (2018): The public health burden of conduct disorder, early mortality and criminal justice involvement.
    Aalsma MC
    Addiction; 2018 Nov; 113(11):2116-2117. PubMed ID: 30215875
    [No Abstract]   [Full Text] [Related]  

  • 11. Commentary: Transdiagnostic neuroscience of child and adolescent mental disorders--differentiating decision-making in attention-deficit/hyperactivity disorder, conduct disorder, depression and anxiety. A commentary on Sonuga-Barke et al. (2016).
    Rohde LA
    J Child Psychol Psychiatry; 2016 Mar; 57(3):350-2. PubMed ID: 26889895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on Heron et al. (2013): Findings on associations between conduct problem trajectories, early risk factors and adolescent cannabis use-how do they fit with existing theories?
    Hemphill SA
    Addiction; 2013 Dec; 108(12):2139-40. PubMed ID: 24237900
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tricyclic antidepressive agents in insomnis. A commentary].
    Lingjaerde O
    Tidsskr Nor Laegeforen; 1971 May; 91(13):975-6. PubMed ID: 5576967
    [No Abstract]   [Full Text] [Related]  

  • 14. Commentary: Childhood conduct problems are a public health crisis and require resources: a commentary on Rivenbark et al. ().
    Burt SA; Hyde LW; Frick PJ; Jaffee SR; Shaw DS; Tremblay R
    J Child Psychol Psychiatry; 2018 Jun; 59(6):711-713. PubMed ID: 29808490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conduct disorder in referred children and adolescents: clinical and therapeutic issues.
    Masi G; Milone A; Manfredi A; Pari C; Paziente A; Millepiedi S
    Compr Psychiatry; 2008; 49(2):146-53. PubMed ID: 18243886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "A two-illness model of bipolar disorder"--RT Joffe, LT Young, and GM MacQueen: a commentary.
    Dunner DL
    Bipolar Disord; 1999 Sep; 1(1):36-7. PubMed ID: 11256654
    [No Abstract]   [Full Text] [Related]  

  • 17. "A two-illness model of bipolar disorder"--by RT Joffe, LT Young, and GM MacQueen: a commentary.
    Bowden CL
    Bipolar Disord; 1999 Sep; 1(1):31-5. PubMed ID: 11256653
    [No Abstract]   [Full Text] [Related]  

  • 18. "A two-illness model of bipolar disorder"--RT Joffe, LT Young, and GM MacQueen: a commentary.
    Swann AC
    Bipolar Disord; 1999 Sep; 1(1):38-41. PubMed ID: 11256655
    [No Abstract]   [Full Text] [Related]  

  • 19. Childhood predictors of use and costs of antidepressant medication by age 24 years: findings from the Finnish Nationwide 1981 Birth Cohort Study.
    Gyllenberg D; Sourander A; Niemelä S; Helenius H; Sillanmäki L; Ristkari T; Piha J; Kumpulainen K; Tamminen T; Moilanen I; Almqvist F
    J Am Acad Child Adolesc Psychiatry; 2011 Apr; 50(4):406-15, 415.e1. PubMed ID: 21421180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on Verweij et al. (2016): Conduct problems and substance use-genetic and environmental perspectives on sex differences.
    Few LR; Agrawal A
    Addiction; 2016 Jun; 111(6):1046-7. PubMed ID: 27157903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.